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abstract
Optimizing antibiotic therapy should mean prompt achievement and maintenance of 
optimal exposure of the antibiotic at the site of infection, administered in a timely manner. Basic 
criteria to be fulfilled are: 1) does the patient really have an infection treatable by antibiotics. 2) 
are microbial samples warranted before starting treatment, because quantitative assessment is 
needed for bacteria isolated from the respiratory tract, while bacteria isolated from cerebrospinal 
fluid, ascites, pleural or articular aspirates are pathogens 3) mono or Combined therapy 4) which 
administration route? 5) duration of therapy and 6) how to prevent resistance. The interaction 
of antibiotic – infection site – pathogen and susceptibility –patients pathophysiology-  is known 
as the antimicrobial therapy puzzle. PK-PD knowledge is of paramount importance. High dose, 
short course regiment with a once daily administration schedule for concentration dependent 
antibiotics e.g. levofloxacin may yield more rapid bacterial killing and prevention of resistance 
development, because its efficacy is related to the achievement of high Cmax / MIC ratio (>10) 
and AUC / MIC ratio, which for gram negative bacteria is > 100-125 and for gram positive 
bacteria > 30-35. Duration of antibiotic therapy can be as short as 5 days, but can also be 
determined by procalcitonin levels of < 0.5 mcg / ml or if it has declined > 80% of its peak 
level.
Keywords:  antimicrobial therapy puzzle – PK = pharmacokinetics- PD = pharmacodynamics 
- Cmax = maximal concentration- MIC = minimal inhibitory concentration – AUC = area 
undercurve–procalcitonin
OPTIMAlISASI TERAPI ANTIBIOTIK PADA PNEuMONIA RAwAT 
INAP
ABSTRAK
Untuk mengupayakan optimalisasi terapi antibiotik diperlukan pencapaian serta 
dipertahankannya konsentrasi antibiotik yang optimal ditempat infeksi pada waktu yang tepat. 
Kriteria dasar yang harus dipenuhi adalah 1) Apakah penderita benar benar menderita penyakit 
infeksi yang bisa ditanggulangi dengan antibiotika. 2) Apakah memerlukan identifikasi spesimen 
mikrobial untuk pemilihan antibiotika, karena infeksi saluran nafas memerlukan assesmen 
kwantitatif. 3) Apakan memerlukan MONO atau terapi KOMBINASI. 4) Rute administrasi 
lewat jalan apa ? 5) Patogen, kepekaan serta patofisioli. 6) Mencegah timbulnya resistensi. 
Interaksi antibiotika – situs infeksi – farmakokinetik – serta farmakodinamik amat penting dan 
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merupakan bagian dari TEKA TEKI terapi antibiotik ( antibiotic puzzle)
Kata kunci : PK – PD – Antibiotic Puzzle - MIC
___________________________________________________________________________
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INTRODuCTION
      Optimizing antibiotic therapy should mean 
prompt achievement and maintenance of 
optimal exposure of the antibiotic at the site of 
infection. Questions that need to be addressed 
are :
Does the patient really have an •	
infection treatable by antibiotics?
Are microbial samples warranted •	
BEFORE starting therapy?
All bacteria isolated from o 
cerebrospinal fluid, asci tes, 
pleural effusions,and articular 
fluid are pathogens, BUT 
quantitative assessment is 
needed for bacteria isolated 
from the respiratory tract.
Mono or combined drug regiments?•	
Which administration route? •	
Duration of therapy•	
How to prevent resistance•	
      The WHO has issued guidelines on the 
Ideal drug usage in much of the same line:
The CORRECT drug, by the best ROUT, at 
the right DOSE, at OPTIMUM INTERVALS, 
for an APPROPRIATE PERIOD, based upon 
an ACCURATE DIAGNOSIS.
So appropiate antibiotic treatment is 
summarize in table 1. Implementation of this 
appropiate antibiotic treatment guide, brings 
forth the problem of the” ANTIMICROBIAL 
THERAPY PUZZLE” requiring knowledge of 
the Pharmacokinetic and Pharmacodynamic 
laws (figure 1)
Table 1.  Appropiated Antibiotic Treatment
Correct choice of antibiotic on the 1) 
basis
Of the antibiograma. 
Invitro bacterial susceptabilityb. 
Timely administration2) 
At the right dosea. 
By the right route and schedule b. 
In short, pharmacokinetic is about the 
dosage regimen and the serum concentration 
it attains, while pharmacodynamics is about 
the biologic effect and the drug concentration 
at the site of infection (figure 2)
Figure 1  : Antibiotic therapy treatment
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Figure 2  : PK – PD Of Antimicrobials
The anti  microbial  therapy  puzzle 
reminds us of the interaction between : the 
antibiotic used – the infection site – the patient’s 
pathophysiology e.g. sepsis / septic shock – 
and- the pathogen and its susceptability. As 
this topic is too broad to be covered here (see 
Pea and Viale), only some points relevant to 
this paper will be mentioned.
Antibiotic at the site of infection, depend 
on the diffusion profile of the drug, whether 
they are hydrophilic or lipophilic ( table 2)
Table 2. Hydrophilic and lipophylic drugs at 
site of infection
Patient pathophysiology, the importance 
of correcting hypoalbuminemia, especially 
when using high protein bound antibiotics e.g. 
teicoplanin, ertapenem, ceftriaxone. Because 
hypoalbuminemia results in an increase in 
the unbound fraction, which results greater 
renal clearance of the drug and less antibiotic 
concentration at the site of infection.
PK-PD parameters of antimicrobials devide 
antimicrobials into 2 broad categories; 1) 
concentration dependent antibiotics and time 
dependent antibiotics (graphically depicted at 
table 3 and figure 3)
Table 3. PK-PD Clinical outcome
 Figure 3 PK-PD parameters of 
antimicrobials
Table 4. Pharmacodynamics activity of 
Fluoro quinolones against Str.pneumoniae
 
Table 5: The importance of rapid bactericidal 
killing
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Table 4, shows why Ciprofloxacine 
is not considered a respiratory quinolone, 
because its AUC/MIC ratio  against Gr(=) 
cocci is only 7, far below the needed ratio of 
30-35, resulting in less bactericidal kill and 
as such less clinical effectiveness and also 
resistance (Table 4 ). The simple explanation 
for this is that dead bugs do not mutate !!.
lEvOflOxACINE 750 mg.
Although Paul Ehrlich’s maxim of high 
dose, short course  was coined in 1913, a 
century ago and meant for parasitic infections, 
Lala Dunbar landmark study in 2002 proved 
that the same holds true for high dose short 
course Levofloxacine in Community Acquired 
Pneumonia (CAP)
At this study, she showed that 
Levofloxacin 750 mg /OD for 5 days vs 
Levofloxacin 500 mg/OD for 10 days, 
gives quicker symptom relief (table 6), with 
comparable safety (table 7), while exposing 
the bacterial ecology to 25% less antibiotic 
and as such decreasing the potential for 
adaptive resistance.
Simple math tells us that 5 days of 750 
mg = 3750 mg, while 10 days of 500 mg is 
5000 mg. (Table 6, 7 )
Table 6. Quicker symptom relief
 
 
         Levofloxacin 750 mg for 5 days provides greater symtom resolution at day 3
Table 7. Comparable safety 750 mg OD -500 
mg OD
DuRATION of ANTIBIOTIC THERAPy 
IN CAP
      There are several suggestions, but no 
precise guidelines, all empirical
IDSA ( Infectious diseases society of •	
America) : 72 hrs afebrile
Canadian infectious and thoracic •	
Society : 1-2 wks
BTS (British Thoracic Society)     •	
: 7-21 days, subj. to clin.judg.
ATS ( American Thoracic Society)  •	
: 7-14 days for hosp.5-7 d out pat.
Using PROCALCITONIN to 
customized duration of antibiotic therapy, 
when its concentration is less than 0.5 ng/
ml or has decreased by more than 80% from 
its peak concentration, antibiotics can be 
stopped, but vigilance must be maintained to 
detect recurrence.
SuMMARy HIGH DOSE SHORT 
COuRSE lEvOflOxACIN IN CAP:
High dose, short course regimen, with a 
once daily administration schedule may yield 
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more rapid  bacterial killing and prevention of 
resistance development, because its efficacy 
is related to the achievement of high Cmax / 
MIC ratio (>10) and auc / mic ratio, which for 
gram (-) bacteria should be > 100-125 and for 
gram (+) > 30-35  
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